Utility of plasma transferrin receptor, ferritin and inflammatory markers in children with sickle cell disease

References

• Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329:9–22.
   PubMed Web of Science ®Google Scholar
• Flowers CH, Skikne BS, Covell AM, Cook JD. The clinical measurement of serum transferrin receptor. J Lab Clin Med. 1989;114:368–77.
   PubMed Web of Science ®Google Scholar
• Baynes RD. Assessment of iron status. Clin Biochem. 1996;29:209–15.
   PubMed Web of Science ®Google Scholar
• Stuart J, Stone PC, Akinola NO, Gallimore JR, Pepys MB. Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease. J Clin Pathol. 1994;47:166–9.
   PubMed Web of Science ®Google Scholar
• Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15:81–8.
   PubMedGoogle Scholar
• Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44:45–51.
   PubMed Web of Science ®Google Scholar
• Serjeant G, Serjeant B, Stephens A, Roper D, Higgs D, Beckford M, et al.. Determinants of haemoglobin level in steady-state homozygous sickle cell disease. Br J Haematol. 1996;92:143–9.
   PubMed Web of Science ®Google Scholar
• Singhal A, Cook JD, Skikne BS, Thomas P, Serjeant B, Serjeant G. The clinical significance of serum transferrin receptor levels in sickle cell disease. Br J Haematol. 1993;84:301–4.
   PubMed Web of Science ®Google Scholar
• Lulla RR, Thompson AA, Liem RI. Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease. Pediatr Blood Cancer. 2010;55:141–4.
   Web of Science ®Google Scholar
• Vichinsky E, Kleman K, Embury S, Lubin B. The diagnosis of iron deficiency anemia in sickle cell disease. Blood. 1981;58:963–8.
   PubMed Web of Science ®Google Scholar
• Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al.. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood. 1995;86:776–83.
   PubMed Web of Science ®Google Scholar
• Al-Saqladi A, Delpisheh A, Bin-Gadeem H, Brabin BJ. Severity of sickle cell disease in Yemeni children. J Trop Pediatr. 2009;55:208–9.
   PubMed Web of Science ®Google Scholar
• El-Hazmi MA, Bahakim HM, Warsy AS, Al-Momen A, Al-Wazzan A, Al-Fawwaz I, et al.. Does G gamma/A gamma ratio and Hb F level influence the severity of sickle cell anaemia. Mol Cell Biochem. 1993;124:17–22.
   PubMed Web of Science ®Google Scholar
• Singhal A, Thomas PW, Serjeant BE, Serjeant GR, Doherty JF, Raynes JG, et al.. Is there an acute-phase response in steady-state sickle cell disease? Lancet. 1993;341:651–3.
   Google Scholar
• Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89:1052–7.
   PubMed Web of Science ®Google Scholar
• Ooi CL, Lepage N, Nieuwenhuys E, Sharma AP, Filler G. Pediatric reference intervals for soluble transferrin receptor and transferrin receptor-ferritin index. World J Pediatr. 2009;5:122–6.
   Web of Science ®Google Scholar
• Kratovil T, De Berardinis J, Gallagher N, Luban NL, Soldin SJ, Wong EC. Age specific reference intervals for soluble transferrin receptor (sTfR). Clin Chim Acta. 2007;380:222–4.
   Web of Science ®Google Scholar
• Duits AJ, Rojer RA, van Endt T, MacGillavry MR, ten Cate H, Brandjes DP, et al.. Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease. Ann Hematol. 2003;82:171–4.
   Web of Science ®Google Scholar
• Croizat H, Nagel RL. Circulating cytokines response and the level of erythropoiesis in sickle cell anemia. Am J Hematol. 1999;60:105–15.
   Web of Science ®Google Scholar
• Tancabelic J, Sheth S, Paik M, Piomelli S. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion. Am J Hematol. 1999;60:121–5.
   Web of Science ®Google Scholar
• Brownell A, Lowson S, Brozovic M. Serum ferritin concentration in sickle cell crisis. J Clin Pathol. 1986;39:253–5.
   Web of Science ®Google Scholar
• Nielsen P, Kordes U, Fischer R, Engelhardt R, Janka GE. SQUID-bio susceptometry in iron overloaded patients with hematologic diseases. Klin Padiatr. 2002;214:218–22.
   PubMed Web of Science ®Google Scholar
• Stettler N, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. Iron status of children with sickle cell disease. J Parenter Enteral Nutr. 2001;25:36–8.
   PubMed Web of Science ®Google Scholar
• Witte DL. Can serum ferritin be effectively interpreted in the presence of the acute-phase response? Clin Chem. 1991;37:484–5.
   Google Scholar
• Rao KR, Patel AR, McGinnis P, Patel MK. Iron stores in adults with sickle cell anemia. J Lab Clin Med. 1984;103:792–7.
   Google Scholar
• Coenen JL, van Dieijen-Visser MP, van Pelt J, van Deursen CT, Fickers MM, van Wersch JW, et al.. Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem. 1991;37:560–3.
   PubMed Web of Science ®Google Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–23.
   PubMed Web of Science ®Google Scholar
• Akinola NO, Stevens SM, Franklin IM, Nash GB, Stuart J. Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol. 1992;45:902–6.
   Google Scholar
• Hedo CC, Aken'ova YA, Okpala IE, Durojaiye AO, Salimonu LS. Acute phase reactants and severity of homozygous sickle cell disease. J Intern Med. 1993;233:467–70.
   PubMed Web of Science ®Google Scholar
• Tumblin A, Tailor A, Hoehn GT, Mack AK, Mendelsohn L, Freeman L, et al.. Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease. Haematologica. 2010;95:1467–72.
   PubMed Web of Science ®Google Scholar
• Makis AC, Hatzimichael EC, Stebbing J, Bourantas KL. C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell disease. Arch Intern Med. 2006;166:366–8.
   Web of Science ®Google Scholar
• Etienne-Julan M, Belloy MS, Decastel M, Dougaparsad S, Ravion S, Hardy-Dessources MD. Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8. Haematologica. 2004;89:863–4.
   PubMed Web of Science ®Google Scholar
• Horowitz IN, Tai K. Hypoalbuminemia in critically ill children. Arch Pediatr Adolesc Med. 2007;161:1048–52.
   Web of Science ®Google Scholar
• Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett. 2002;9:211–23.
   PubMed Web of Science ®Google Scholar
• Al-Saqladi AW, Harper G, Delpisheh A, Fijnvandraat K, Bin-Gadeem HA, Brabin BJ. Frequency of the MTHFR C677T polymorphism in Yemeni children with sickle cell disease. Hemoglobin. 2010;34:67–77.
   PubMed Web of Science ®Google Scholar
• Hurt N, Smith T, Teuscher T, Tanner M. Do high levels of C-reactive protein in Tanzanian children indicate malaria morbidity? Clin Diagn Lab Immunol. 1994;1:437–44.
   Google Scholar